At the beginning of November IMU noted 2 "value inflection points" for Hervaxx over the next 12 months.
At the AGM - Hervaxx is no longer represented on this slide for the next 12 months. I did see that a couple of posters stated that IMU are in discussions with BP. So far IMU haven't been able to put together a deal with BP at all and apparently they have been in discussions with BP 'day and night' for some time now. What happens if they cant do the deal with BP? Why are they no longer producing Hervaxx phase 2 information in Q4 2023 as suggested only 5 weeks ago?
At the beginning of November IMU noted 2 "value inflection...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |